menu

Non-CF Bronchiectasis (NCFBE): Redefined

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Non-CF Bronchiectasis: Navigating the Chronic Cough Vortex

Non-CF Bronchiectasis (NCFBE): Redefined

MinuteCE®
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
1.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    An estimated 350,000-500,000 adults are affected by bronchiectasis in the United States, and up to 90% of patients with bronchiectasis present with chronic cough. This educational activity provides a framework of treatment options for NCFBE, empowering medical practitioners to work collaboratively with pulmonary specialists and confidently proceed with a sustainable treatment plan that is evidence-based and makes sense for both practitioner and patient.

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, including pulmonologists, radiologists, primary care or family medicine practitioners’, physician assistants, nurse practitioners, nurses, pharmacists and any other clinicians involved in the management of patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE).

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Discuss epidemiological data supporting NCFBE as a clinically relevant disease that is more common than previously described
    • Identify common etiologies and the clinical presentation of this disease, emphasizing overlap with comorbid medical conditions routinely seen in clinical practice
    • Review the complex pathophysiology of how NCFBE leads to progressive decline in lung function
    • Review the current recommended diagnostic algorithm, with emphasis on the importance of early diagnosis and pulmonary referral
    • Review the current treatment options and potential future pharmaceutical options for the management of NCFBE
  • Accreditation and Credit Designation Statements


    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Ashwin Basavaraj, MD, FCCP, ATSF, faculty for this educational event, receives research funds from Baxter; and receives consulting fees from Insmed, Baxter, Zambon, Dymedso, and Physio-Assist.

    Pamela J. McShane, MD, faculty for this educational event, receives research funds from Boehringer Ingelheim, Armata, Renovian, AN2 Therapeutics, and Insmed; and receives consulting fees from Insmed and Boehringer Ingelheim. 

    Colin Swenson, MD, faculty for this educational event, receives research funds from Insmed, Electromed, and Paratek; and receives consulting fees from Insmed. 

    Gregory Tino, MD,  faculty for this educational event, receives research funds from US Bronchiectasis and NTM Research Registry-COPD Foundation; and receives consulting fees from Insmed and Astra Zeneca.

    Jungae Kole, RN, BSN, faculty for this educational event, has no relevant financial relationships with ineligible companies. 

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    Prerna Poojary, PhD, planner for this educational event, has no relevant financial relationships with ineligible companies.

    Alison S. Kole, MD, MPH, FCCP, FAASM, planner for this educational event, has no relevant financial relationships with ineligible companies.

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    Total CME, LLC planners and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Acknowledgment

    This activity is supported by an independent educational grant from Insmed Incorporated.

    Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.

  • Fee Statements

    This activity is FREE to all participants.

  • Instructions for Completion

    During the period 6/16/2023 through 6/15/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:

    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule25 Sep 2023